Paul Sekhri is the founder of EGenesis. EGenesis has raised $125M in total funding. Latest round: Series C.
Paul Sekhri has over 30 years of experience in the Life Science Industry, holding senior management roles in pharmaceutical and biotechnology companies, as well as in private equity and venture capital. He served as President and CEO of eGenesis, Inc. from 2019-2022 and currently remains a Board Member and Senior Advisor to the Chairman at the company. He is also currently the President and Chief Executive Officer of vTv Therapeutics, Inc. and sits on over a dozen other boards.
Full founder directory · Investor directory · Company funding database · Fundraising library